Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-7 of 7
Keywords: Solifenacin
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Mirabegron versus Solifenacin in Children with Overactive Bladder: Prospective Randomized Single-Blind Controlled Trial
Available to PurchaseSubject Area:
Further Areas
Mohamed G. Soliman, Shawky El-Abd, Osama M. El-Gamal, Ali Abdel Raheem, Ahmed R. Abou-Ramadan, Ahmed S. El-Abd
Journal:
Urologia Internationalis
Urol Int (2021) 105 (11-12): 1011–1017.
Published Online: 19 May 2021
...Mohamed G. Soliman; Shawky El-Abd; Osama M. El-Gamal; Ali Abdel Raheem; Ahmed R. Abou-Ramadan; Ahmed S. El-Abd Purpose: The purpose of this study is to investigate the efficacy and safety of mirabegron versus solifenacin in the treatment of newly diagnosed overactive bladder (OAB) in children...
Journal Articles
Comparisons of Therapeutic Efficacy and Safety of Solifenacin versus Tolterodine in Patients with Overactive Bladder: A Meta-Analysis
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2019) 103 (2): 187–194.
Published Online: 06 June 2019
...Hai-Tao Wang; Ming Xia Objectives: This meta-analysis was to assess solifenacin and tolterodine in patients with overactive bladder. Methods: We searched PubMed, the Cochrane Library, EMBASE, CNKI, Wanfang, and ClinicalTrials.gov databases for randomized controlled trials (RCTs). The efficacy...
Journal Articles
Solifenacin in the Elderly: Results of an Observational Study Measuring Efficacy, Tolerability and Cognitive Effects
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2017) 98 (3): 350–357.
Published Online: 02 February 2017
...Christian Hampel; Dietmar Betz; Maximilian Burger; Christoph Nowak; Monika Vogel Introduction: The study aimed to evaluate the efficacy and safety of solifenacin in older patients with overactive bladder (OAB). Materials and Methods: Observational data on patients aged ≥70 years and the prescribed...
Journal Articles
Comparison of Therapeutic Efficacy and Urodynamic Findings of Solifenacin Succinate versus Mirabegron in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Study
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2016) 97 (3): 325–329.
Published Online: 20 April 2016
...Carlo Vecchioli Scaldazza; Carolina Morosetti Introduction: We assessed clinical and urodynamic effects of solifenacin versus mirabegron in women with overactive bladder (OAB) syndrome. Material and Methods: Eighty women with OAB were randomized into 2 groups. In group A, the patients received...
Journal Articles
Comparative Effectiveness of Combined Low- and Standard-Dose Trospium and Solifenacin for Moderate Overactive Bladder Symptoms in Elderly Men and Women
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2014) 93 (4): 470–473.
Published Online: 28 August 2014
... according to the method of treatment as follows: group А1: n = 57, trospium 30 mg/day + solifenacin 10 mg/day; group А2: n = 61, trospium 15 mg/day + solifenacin 5 mg/day; group А3: n = 59, placebo. All patients underwent a urodynamic examination in accordance with international standards before and 2...
Journal Articles
Acupuncture versus Solifenacin for Treatment of Overactive Bladder and Its Correlation with Urine Nerve Growth Factor Levels: A Randomized, Placebo-Controlled Clinical Trial
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2014) 93 (4): 437–443.
Published Online: 16 July 2014
...Yasin Aydoğmuş; Melih Sunay; Hüseyin Arslan; Arif Aydın; Ali Kudret Adiloğlu; Hünkar Şahin Objective: To determine whether acupuncture is effective as an overactive bladder (OAB) treatment compared with solifenacin and placebo, and to investigate its relation with urine nerve growth factor (NGF...
Journal Articles
Long-Term Safety and Efficacy of Two Different Antimuscarinics, Imidafenacin and Solifenacin, for Treatment of Overactive Bladder: A Prospective Randomized Controlled Study
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2013) 90 (2): 161–167.
Published Online: 27 November 2012
...Teruhiko Yokoyama; Takao Koide; Ryoei Hara; Kazuhiko Fukumoto; Yoshiyuki Miyaji; Atsushi Nagai Objective: The aim of this study was to assess the efficacy and safety of long-term treatment with two different antimuscarinics, imidafenacin and solifenacin, in patients with overactive bladder (OAB...